| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -37,283 | -28,966 |
| Proceeds from the exercise of stock options | 16 | 16 |
| Principal payments of insurance financing | 317 | 196 |
| Net cash provided by (used in) financing activities | -301 | -180 |
| Effect of exchange rate changes on cash and cash equivalents | 21 | 27 |
| Net decrease in cash and cash equivalents | -37,563 | -29,119 |
| Cash and cash equivalents at beginning of period | 47,249 | - |
| Cash and cash equivalents at end of period | 9,686 | - |
LEAP THERAPEUTICS, INC. (LPTX)
LEAP THERAPEUTICS, INC. (LPTX)